Effect of long period treatment with erythropoiesis stimulating agents on clinically and laboratory parameters in hemodialysis autosomal dominant polycystic kidney disease patients

Effect of long period treatment with erythropoiesis stimulating agents on clinically and laboratory parameters in hemodialysis autosomal dominant polycystic kidney disease patients

Introduction. The study of dialysis patients not needing erythropoiesis-stimulating agents (ESA) for long periods of time has gained interest lately. The aim of this study was to compare laboratory and clinical parameters in hemodialysis patients with autosomal dominant polycystic kidney disease (AD...

Full description

Bibliographic Details
Main Authors: Orăsan Olga Hilda, Petrov Ljubomir, Urian Laura, Cozma Angela, Ciulei George, Patiu Ioan Mihai, Orăsan Remus Aurel
Format: Article
Language:English
Published: Sciendo 2017-10-01
Series:Romanian Journal of Laboratory Medicine
Subjects:
autosomal dominant polycystic kidney disease
erythropoiesis-stimulating agents
anemia
hemodialysis
Online Access:https://doi.org/10.1515/rrlm-2017-0032

Internet

https://doi.org/10.1515/rrlm-2017-0032

Similar Items